Main > ONCOLOGY (**) > Ovarian Cancer>FRα(+)>PROC > TREAT.: > USA. A. FRα(+) Binding Ab-Link

---

USA. A. FRα(+) Binding Ab-Link's subsections
(*) USA Full Approval: 2024. 03.22
>er Tubulin Inhibitor ADC
Company
Generic Name
PR Web-Site
RTM
USA Patent APP Number

USA. A. FRα(+) Binding Ab-Link's products
This section has no products